MUC2 and cancer: We examined the MUC2-MS2 minisatellites in DNA from blood and cancer tissue derived from 28 patients with gastric cancer, and detected four cases with small deletions or loss of heterozygosity (LOH) in MUC2-MS2 (Figure 3B); frequency of rearrangement was 14.3%.